Prevalence of overactive bladder (OAB) in patients with pelvic organ prolapse (POP) and predictors of symptoms of OAB after surgical correction of POP.

Prevalence of overactive bladder (OAB) in patients with pelvic organ prolapse (POP) and predictors of symptoms of OAB after surgical correction of POP. - OAB&POP: overactive bladder in women with prolapse before and after surgery

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35445

Enrollment

100

Registered

2012-01-05

Start date

2012-02-20

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

in women with genital prolapse Overactive bladder symptoms in women with pelvic organ prolapse - Frequent and strong desire to void with or without urinary incontinence

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Female patients, age 18 or greater, with a pelvic organ prolapse POP-Q stage II to IV . - Patient will undergo prolapse repair surgery. - Patient understands the Dutch written and spoken language.

Exclusion criteria

Exclusion criteria: - Patients who currently use anticholinergic medication. - Patients with neurological causes of OAB. - Patients who are pregnant or wish to become pregnant. - Patients with a history of cancer in the pelvic region, treated with radiotherapy or surgery.

Design outcomes

Primary

Measure	Time frame
Main study parameters are the presence of bothersome OAB as measured by bladder diary and validated disease specific questionnaires (UDI, IIQ, ICIQ-FLUTS, OABSS) and the outcomes of urodynamic studies (presence of detrusor overactivity (DO), bladder outflow obstruction (BOO)).	—

Secondary

Measure	Time frame
Secondary parameters are the outcomes of measurement of POP-Q, ultrasound assesment of bladder wall thickness (BWT) and configuration of urethra and bladder neck, analysis of urinary biomarkers, and the findings of cystoscopy (presence of trabeculation).	—

Countries

Netherlands

Outcome results